Northern Ireland’s Chief Pharmaceutical Officer Cathy Harrison has launched the Know, Check, Ask campaign to highlight the importance of using medicine safely.
Contractors and pharmacy teams providing this service are asked to please promote this campaign via their social media channels.
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Contractor
CPNI has been liaising with the Pharmaceutical Society Northern Ireland (PSNI) in relation to the registration process and timeline for Foundation Training Year (FTY) pharmacists intending to register with PSNI this summer.
PSNI has confirmed the following:
PSNI will open the portal to registration applications on 1 July 2022. The Common Registration Assessment (CRA) results will be available on 29 July 2022. From 1 August 2022, PSNI will begin to process all completed applications that they receive by 15 July 2022 from FTY pharmacists who have; completed the FTY programme, been successful in the CRA and paid the relevant fees. PSNI will aim to Register all those who have completed the steps outlined above on or before Friday, 5 August 2022, with subsequent applications being processed in order received thereafter.
Contractors are advised to encourage Foundation Year pharmacists to properly complete their online applications and to ensure they have completed all the necessary elements of their FTY training with NICPLD and tendered the relevant payment to the PSNI on time.
It is anticipated that PSNI will confirm these arrangements and provide further information on their website in due course, but hopefully this information will, in the meantime, help you in the planning of your pharmacy staffing arrangements going forward.
Please do not hesitate to contact the CPNI office should you require any further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
Please see attached correspondence from Kathryn Turner, Pharmacy Lead, Strategic Planning and Performance Group.
SUMMARY
The latest campaign “Know Check Ask” commenced on 25 April 2022 and has been extended until 30 June 2022.
All printable and additional resources and information will be available HERE.
As per the service specification, SPPG request that you display the posters in at least one window unit of the pharmacy.
There is a range of additional resources to support this campaign, all available HERE.
If you have not received your “Know Check Ask” resource pack, please email reception.pha@hscni.net and ensure your email subject heading is titled “LIVING WELL PHARMACY CAMPAIGN”.
Contractors and pharmacy teams providing this service are asked to please promote this campaign via social media channels.
If you have any queries in relation to these changes, please contact your local Integrated Care Office.
Please do not hesitate to contact the CPNI office should you require any further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
The first update of concessionary prices were granted for May 2022:
Drug
Pack Size
Concessionary Price
Atenolol 50mg tablets
28
£0.79
Baclofen 5mg/5ml oral solution sugar free
300
£2.29
Bimatoprost 100micrograms/ml eye drops
3
£4.42
Brimonidine 0.2% eye drops
5
£4.99
Celecoxib 100mg capsules
60
£6.28
Celecoxib 200mg capsules
30
£6.99
Clarithromycin 500mg tablets
14
£1.95
Co-amilozide 5mg/50mg tablets
28
£18.95
Co-codamol 30mg/500mg effervescent tablets
32
£2.03
Co-codamol 30mg/500mg effervescent tablets
100
£6.34
Cyanocobalamin 50microgram tablets
50
£14.49
Esomeprazole 40mg gastro-resistant tablets
28
£5.50
Gabapentin 600mg tablets
100
£6.75
Hydroxocobalamin 1mg/1ml solution for injection ampoules
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Colleague
As you are aware on 22 March 2022 Mr. Robin Swann MLA, Health Minister announced an additional funding of £8m into community pharmacy in 2021/22 in recognition of adherence services provided last year.
Work is now being prioritised and taken forward with SPPG to develop and introduce adherence support services in 2022/23. The first phase will be the introduction of an Interim Community Pharmacy Medicines Adherence Service for hospital and intermediate care discharge patients (cohort 3).
Until such times that service specification and funding is finalised, and shared with you, there remains no mechanism for community pharmacies to take on new patients. The letter issued by SPPG on 31 March 2022 remains the current position and this letter can be shared with other healthcare professionals enquiring about the proposed new service.
Please do not hesitate to contact the CPNI office should you require any further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
